Copyright
©The Author(s) 2024.
World J Methodol. Sep 20, 2024; 14(3): 91832
Published online Sep 20, 2024. doi: 10.5662/wjm.v14.i3.91832
Published online Sep 20, 2024. doi: 10.5662/wjm.v14.i3.91832
Table 1 Baseline characteristics of 106 type 2 diabetes mellitus patients treated with semaglutide
| Attributes | Male | Female | All | Reference value (if applicable) | |||
| Mean | (SD) | Mean | (SD) | Mean | (SD) | ||
| Patient age (years) | 60.88 | (10.04) | 60.64 | (12.43) | 60.76 | (11.18) | |
| Systolic blood pressure (mm Hg) | 140.43 | (18.42) | 136.79 | (15.18) | 138.86 | (17.02) | |
| Diastolic blood pressure (mm Hg) | 80.32 | (10.82) | 71.32 | (10.62) | 76.45 | (11.56) | |
| Patient baseline weight (kg) | 111.45 | (21.07) | 109.05 | (28.63) | 110.36 | (24.56) | |
| Patient baseline HbA1c (mmol/mol) | 84.18 | (22.20) | 79.46 | (19.40) | 81.96 | (20.96) | 20-41 mmol/mol |
| Serum creatinine (μmol/L) | 101.16 | (53.98) | 75.33 | (37.18) | 89.34 | (48.52) | Male: 59-104 μmol/L; Female: 45-84 μmol/L |
| Urine ACR (mg/mmol) | 21.96 | (38.26) | 28.74 | (58.59) | 24.97 | (47.81) | Male: < 2.5 mg/mmol; Female: < 3.5 mg/mmol |
| Total cholesterol (mmol/L) | 4.10 | (1.47) | 4.53 | (1.16) | 4.29 | (1.35) | < 5.01 mmol/L |
| HDL (mmol/L) | 1.07 | (0.34) | 1.16 | (0.36) | 1.11 | (0.35) | > 1 mmol/L |
| Triglyceride (mmol/L) | 4.82 | (5.79) | 5.02 | (2.62) | 4.89 | (4.60) | < 2.3 mmol/L |
| ALT (U/L) | 25.50 | (15.04) | 23.73 | (11.17) | 24.69 | (13.33) | 0-33 U/L |
- Citation: Alkhalifah M, Afsar H, Shams A, Blaibel D, Chandrabalan V, Pappachan JM. Semaglutide for the management of diabesity: The real-world experience. World J Methodol 2024; 14(3): 91832
- URL: https://www.wjgnet.com/2222-0682/full/v14/i3/91832.htm
- DOI: https://dx.doi.org/10.5662/wjm.v14.i3.91832